| Trial ID: | L4903 |
| Source ID: | NCT03056014
|
| Associated Drug: |
N-Acetyl Cysteine
|
| Title: |
Antioxidant Use in Diabetes to Reduce Oxidative Stress
|
| Acronym: |
|
| Status: |
TERMINATED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Ameliorating Oxidative Stress in Type 1 Diabetes
|
| Interventions: |
DRUG: N-acetyl cysteine|DIETARY_SUPPLEMENT: omega 6 Fish oil ( PUFA)|DIETARY_SUPPLEMENT: Placebo
|
| Outcome Measures: |
Primary: Change from baseline in level of oxidative stress with varying doses of NAC at 2 weeks., 2 weeks|Change from baseline in level of oxidative stress with varying doses of omega 6 fish oil(PUFA) at 2 weeks., 2 weeks |
|
| Sponsor/Collaborators: |
Sponsor: University of Maryland, Baltimore
|
| Gender: |
FEMALE
|
| Age: |
ADULT
|
| Phases: |
EARLY_PHASE1
|
| Enrollment: |
8
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT
|
| Start Date: |
2018-11-01
|
| Completion Date: |
2020-03-12
|
| Results First Posted: |
|
| Last Update Posted: |
2022-03-22
|
| Locations: |
University of Maryland, Baltimore, Baltimore, Maryland, 21201, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT03056014
|
